文献速递乳腺MR乳腺X线US

超快速MRI预测导管原位癌手术升级为浸润癌

Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.
PubMed 文献 · AJR Am J Roentgenol · 2023-02-08

该研究纳入了68例活检证实为纯导管原位癌(DCIS)的患者,术前均行超快速MRI(UF-MRI)和常规动态增强MRI(DCE-MRI),术后病理显示26例(38%)升级为浸润癌。UF-MRI上的强化时间(TTE)较短(阈值11秒)与升级显著相关,DCE-MRI和乳腺X线上的病灶较大也与升级显著相关。联合TTE和所选特征进行逻辑回归的AUC为0.85,但未达统计学显著性。

要点

  • 联合TTE和病灶大小可提高预测升级的AUC至0.85。

诊断标准与关键数值

  • UF-MRI TTE阈值为11秒时,预测升级的敏感度为76%,特异度为50%。
  • DCE-MRI病灶大小阈值为4.4 cm时,预测升级的敏感度为88%,特异度为56%。
  • 联合TTE和所选特征的逻辑回归模型AUC为0.85(预测升级),但无统计学显著性。

临床应用与阅片要点

  • 术前UF-MRI TTE和DCE-MRI病灶大小可用于评估DCIS升级风险,辅助手术规划(如是否行前哨淋巴结活检)。
  • 注意TTE和病灶大小阈值来自单中心小样本,需谨慎解读。

局限性

  • 单中心回顾性研究,样本量较小(68例)。
  • 联合模型AUC提高无统计学显著性。
  • 未报告其他变量与升级的显著关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Biopsy-proven ductal carcinoma in situ (DCIS) lesions are often upgraded to invasive cancer at surgery. Therefore, accurate prediction of the likelihood of invasion is helpful for surgical planning, including the need for sentinel lymph node biopsy (SLNB). OBJECTIVE. The purpose of the present study was to investigate whether kinetic features of clinically available ultrafast MRI (UF-MRI) can predict upgrade of biopsy-proven DCIS to invasive cancer at surgical excision. METHODS. Consecutive patients with biopsy-proven pure DCIS lesions who underwent UF-MRI with conventional dynamic contrast-enhanced MRI (DCE-MRI) and subsequently underwent surgery between August 2019 and January 2021 were identified. Patient and lesion characteristics, biopsy method and pathology, and lesion features on mammography, ultrasound, DCE-MRI, and UF-MRI were assessed to determine predictors of upgrade to invasive cancer. The Fisher exact test and Kruskal-Wallis test were used for association analysis. RESULTS. In 68 patients (median age, 52.0 years; range, 31-79 years) with 68 biopsy-proven pure DCIS lesions, 26 lesions (38%) were upgraded from in situ to invasive cancer. An upgrade of DCIS to invasive cancer was significantly associated with a shorter time to enhancement (TTE) on preoperative UF-MRI (p = .03), with a threshold of 11 seconds providing maximum specificity (50%) and sensitivity (76%) for upgrade. Larger lesion size on DCE-MRI (p = .001) and mammography (p = .04) was also significantly associated with upgrade; an optimal predictive threshold of 4.4 cm on DCE-MRI yielded sensitivity of 88% and specificity of 56%. No other specific variables were significantly associated with upgrade after surgery. Logistic regression of selected features combined with TTE produced a higher AUC (0.85) in predicting upgrade to invasive disease than did each factor alone, but this result was not statistically significant. CONCLUSION. Preoperative UF-MRI TTE and lesion size on DCE-MRI and mammography show potential in predicting upgrade of DCIS to invasive cancer at surgery. CLINICAL IMPACT. UF-MRI provides useful information that can be used in surgical planning, including determination of the need to perform SLNB.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Miceli, Gao, Qian, et al. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging. AJR Am J Roentgenol. 2023. PMID: 36752370. doi:10.2214/AJR.22.28698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。